BioPharma Credit (LSE:BPCR) YoY Rev. per Sh. Growth : 174.19% (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. BioPharma Credit's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 was 174.19%.

BioPharma Credit's Revenue per Share for the six months ended in Dec. 2022 was $0.09.

BioPharma Credit YoY Rev. per Sh. Growth Historical Data

The historical data trend for BioPharma Credit's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit YoY Rev. per Sh. Growth Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

12.50

-26.67

-3.03

110.94

-37.78

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial							10.00	-13.89	51.52	174.19	-100.00

BioPharma Credit YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

BioPharma Credit's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.084	-	0.135)	/	\| 0.135 \|
=	-37.78 %

BioPharma Credit's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2022 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2022 )
=	(Revenue per Share (Q: Dec. 2022 )	-	Revenue per Share (Q: Dec. 2021 ))	/	\| Revenue per Share (Q: Dec. 2021 )) \|
=	(0.085	-	0.031)	/	\| 0.031 \|
=	174.19 %

BioPharma Credit YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines